NCT03622749

Brief Summary

The investigators are conducting this research study to better understand how individuals with bipolar disorder regulate their emotions, and if the study can use a technique called "transcranial magnetic stimulation" or TMS to help improve emotion regulation for individuals with bipolar disorder.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
19

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2019

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 11, 2018

Completed
29 days until next milestone

First Posted

Study publicly available on registry

August 9, 2018

Completed
7 months until next milestone

Study Start

First participant enrolled

March 1, 2019

Completed
4.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2023

Completed
1.4 years until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2025

Completed
1.2 years until next milestone

Results Posted

Study results publicly available

March 3, 2026

Completed
Last Updated

March 3, 2026

Status Verified

February 1, 2026

Enrollment Period

4.4 years

First QC Date

July 11, 2018

Results QC Date

December 19, 2025

Last Update Submit

February 28, 2026

Conditions

Outcome Measures

Primary Outcomes (4)

  • Affective Multisource Interference Task - Reaction Time During Negative Interference Trials

    The Affective Multisource Interference Task is a behavioral task measuring the ability to identify an oddball number when overlayed on affective images as a proxy for emotion regulation. Outcome Measure 1: Slope of reaction time during trials with negative valenced stimuli where the oddball number is other than zero and in a location incongruent with the location on the button box

    Task administered 10 minutes pre TMS and 5 minutes post TMS

  • Affective Multisource Interference Task - Reaction Time During Positive Interference Trials

    The Affective Multisource Interference Task is a behavioral task measuring the ability to identify an oddball number when overlayed on affective images as a proxy for emotion regulation. Outcome Measure 2: Slope of reaction time during trials with positive valenced stimuli where the oddball number is other than zero and in a location incongruent with the location on the button box

    Task administered 10 minutes pre TMS and 5 minutes post TMS

  • Emotion Conflict Resolution Task - Incongruent Fear Trials Reaction Time

    The Emotion Conflict Resolution Task is a behavioral task requiring correct identification of an emotion word overlayed on photographs of facial expressions of emotion. Outcome measure 3: Slope of reaction time during trials when the image is of a fearful facial expression but the word is "Happy" (incongruent)

    Task administered 10 minutes pre TMS and 5 minutes post TMS

  • Emotion Conflict Resolution Task - Incongruent Happy Trials Reaction Time

    The Emotion Conflict Resolution Task is a behavioral task requiring correct identification of an emotion word overlayed on photographs of facial expressions of emotion. Outcome measure 4: Slope of reaction time during trials when the image is of a happy facial expression but the word is "Fear" (incongruent)

    Task administered 10 minutes pre TMS and 5 minutes post TMS

Study Arms (1)

Patients

ACTIVE COMPARATOR

Individuals with Bipolar 1 Disorder

Device: Transcranial Magnetic Stimulation (TMS)

Interventions

Non-Invasive neuromodulation

Patients

Eligibility Criteria

Age18 Years - 55 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Patients
  • Men and women
  • Ages 18-50 years
  • Patients diagnosed with bipolar I disorder (BD-I), current mood state euthymic.
  • On a stable psychiatric medication regimen for at least a month prior to and during study participation
  • Healthy Controls:
  • Men and women
  • Ages 18-50 years
  • Without major psychiatric illness

You may not qualify if:

  • Patients
  • Any change in psychiatric medications within a month prior to and during study participation
  • Legal or mental incompetency
  • Intellectual disability
  • Current manic (YMRS \> 12) or severe depressive episode (HAM-D-17 \> 5)
  • Substance use disorder (abuse or dependence) with active use within the last 3 months
  • Significant medical or neurological illness
  • Prior neurosurgical procedure
  • History of seizures
  • History of ECT treatment or clinical TMS within the past three months
  • Implanted cardiac pacemakers
  • Patients who have conductive, ferromagnetic or other magnetic-sensitive metals implanted in their head or neck, or are non-removable and within 30 cm of the treatment coil. These include:
  • Aneurysm clips or coils
  • Carotid or cerebral stents
  • Metallic devices implanted in the head (e.g. Implanted pacemaker, medication pump, vagal stimulator, deep brain stimulator, TENS unit, or ventriculo-peritoneal shunt)
  • +30 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Martinos Center for Biomedical Imaging

Charlestown, Massachusetts, 02129, United States

Location

MeSH Terms

Conditions

Bipolar Disorder

Interventions

Transcranial Magnetic Stimulation

Condition Hierarchy (Ancestors)

Bipolar and Related DisordersMood DisordersMental Disorders

Intervention Hierarchy (Ancestors)

Magnetic Field TherapyTherapeutics

Limitations and Caveats

The current study is intended to collect pilot data and therefore uses a small sample, which limits the interpretability of the results. All results from this study should thus be interpreted with caution.

Results Point of Contact

Title
Kristen K. Ellard, PhD
Organization
Massachusetts General Hospital

Study Officials

  • Kristen K Ellard, PhD

    Massachusetts General Hospital

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Masking Details
Participants are blinded to whether they received active versus sham (placebo) TMS.
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Instructor in Psychology

Study Record Dates

First Submitted

July 11, 2018

First Posted

August 9, 2018

Study Start

March 1, 2019

Primary Completion

August 1, 2023

Study Completion

January 1, 2025

Last Updated

March 3, 2026

Results First Posted

March 3, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will not share

Locations